A New Drug Slows Alzheimer’s By One-Third (M)

Patients were also 40 percent less likely to progress from mild cognitive impairment to full-blown dementia after taking the drug.

Patients were also 40 percent less likely to progress from mild cognitive impairment to full-blown dementia after taking the drug.

Keep reading with a Premium Membership

• Read members-only and premium articles
• Access courses
• Adverts removed
• Cancel at any time
• 14 day money-back guarantee for new members

Join Premium

Author: Dr Jeremy Dean

Psychologist, Jeremy Dean, PhD is the founder and author of PsyBlog. He holds a doctorate in psychology from University College London and two other advanced degrees in psychology. He has been writing about scientific research on PsyBlog since 2004.